SERRE, C. H., & Barthelemy, N. (December 2021). Comment reconnaître un patient en situation palliative ? Une question «surprise» pour ne plus se laisser surprendre. Revue Médicale de Liège, 76 (12), 879 - 883. |
Kirkove, D., BARTHELEMY, N., COUCKE, P., MIEVIS, C., BEN MUSTAPHA, S., Dardenne, N., Jodogne, S., & Pétré, B. (28 May 2021). Etude pilote : évaluation de l'impact de l'utilisation de l'imagerie médicale comme outil d'éducation thérapeutique du patient en radiothérapie [Paper presentation]. 8ème Congrès de la Société d'Education Thérapeutique Européenne. |
SERRE, C. H., BRICHANT, G., DEVOS, M., Emscp, & Barthelemy, N. (May 2021). Une bonne gestion de la fin de vie, ou le respect de la qualité de vie. Revue Médicale de Liège, 76 (5-6), 565 - 568. |
Janvary, Z. L., JANSEN, N., BAART, V., DEVILLERS, M., DECHAMBRE, D., LENAERTS, E., SEIDEL, L., BARTHELEMY, N., BERKOVIC, P., GULYBAN, A., lakosi, F., zsolt, H., & COUCKE, P. (2017). Clinical outcomes of 130 patients with primary and secondary lung tumors treated with Cyberknife robotic stereotactic body radiotherapy. Radiology and Oncology, 51 (2), 178-186. doi:10.1515/raon-2017-0015 |
SIBILLE, A., PAULUS, A., MARTIN, M., BOURHABA, M., Barthélemy, N., Radermecker, M., CORHAY, J.-L., LOUIS, R., & DUYSINX, B. (September 2015). PRISE EN CHARGE DU CANCER BRONCHIQUE NON A PETITES CELLULES. Revue Médicale de Liège, 70 (9), 432-41. |
BARTHELEMY, N., BOGA, D., PRINCEN, F., THIRION, C., DAMAS, F., BRICHANT, J.-F., & COUCKE, P. (2014). Quelle est la place de l'humain au sein des recommandations, des concertations oncologiques multidisciplinaires et du projet thérapeutique. Revue Médicale de Liège, 69 (Supp 1), 9-12. |
BARTHELEMY, N., LENNERTS, E., MEYNS, M., DUYSINX, B., PAULUS, A., COMPERE, C., BOSQUEE, L., JERUSALEM, G., & COUCKE, P. (2014). LE DÉFI DU CONTRÔLE LOCAL DANS LE CANCER PULMONAIRE NON A PETITES CELLULES, LOCALEMENT AVANCE, NON OPERABLE. Revue Médicale de Liège, 69 (Supp 1), 75-80. |
BARTHELEMY, N.* , Streel, S.* , Donneau, A.-F., COUCKE, P., Albert, A., & Guillaume, M. (2014). Screening for malnutrition in lung cancer patients undergoing therapy. Supportive Care in Cancer, 22 (6), 1531–1536. * These authors have contributed equally to this work. |
BARTHELEMY, N., JANSEN, N., GENNIGENS, C., DELGAUDINE, M., & COUCKE, P. (2012). y a-t-il une place pour la radiothérapie en fin de vie ? Revue Médicale de Liège, 67 (3), 128/132. |
DELGAUDINE, M., PRINCEN, F., BARTHELEMY, N., LANG, J., LENAERTS, E., & COUCKE, P. (2011). Démarches dans le cadre de l’amélioration globale de la Qualité et de la Sécurité dans le service de Radiothérapie [Poster presentation]. Semaine de la sécurité. |
RONDIA, K., VANDER STEICHEL, D., Barthelemy, N. (Other coll.), & HUMBLET, Y. (Other coll.). (2009). Le traitement du cancer. Le Vif. L'Express. |
Keirse, E. (Ed.), Beguin, C. (Ed.), Desmedt, M. (Ed.), Deveugele, M. (Ed.), Menten, J. (Ed.), Simoens, S. (Ed.), WENS (Ed.), BORGERMANS, L. (Ed.), KOHN, L. (Ed.), Spinnewijn, B. (Ed.), Carrdinael, A. (Ed.), KUTTEN, B. (Ed.), VANDEN BERGHE, P. (Ed.), PAULUS, D. (Ed.), & Barthelemy, N. (Other coll.). (2009). Organisation des soins palliatifs en Belgique. |
Barthelemy, N., Andrien, M., Lecomte, M., Ferir, C., & Serpe, P. (October 2008). Résistance des soignants à la mise en pratique des soins palliatifs : construction d’un modèle causal. Médecine Palliative: Soins Continus, Accompagnement, Éthique, 7 (5). doi:10.1016/j.medpal.2007.12.002 |
Coucke, P., Barthelemy, N., Jansen, N., Trivière, N., & Jerusalem, G. (February 2008). Carcinome intracanalaire (in situ) du sein : pouvons-nous raisonnablement éviter la radiothérapie pour certaines patientes opérées ? Revue Médicale de Liège, 63 (2), 75-81. |
Coucke, P., Barthelemy, N., Bosquee, L., & Van Meerbeeck. (2008). Is an evidence-based approach unrealistic in NSCLC? Belgian Journal of Medical Oncology, volume 2 (6), 326-333. |
Coucke, P., Barthelemy, N., Hustinx, R., & Fillet, G. (2008). Risk adaptive treatment in Hodgkin's lympoma: reduction of radiation dose and irradiated volume. Belgian Journal of Medical Oncology, 2 (2), 85-97. |
Coucke, P., Barthelemy, N., Jansen, N. (Other coll.), Triviere, N. (Other coll.), & Jerusalem, G. (Other coll.). (2008). Carcinome intracanalaire (in situ) du sein : pouvons-nous raisonnablement éviter les radiothérapie pour certaines patientes opérées? Revue Médicale de Liège, 63 (2), 75-81. |
Barthelemy, N., Rinken, F., Dekoster, G., & Bosquee, L. (November 2006). Efficacy and Morbidity of a Novel Induction Treatment in Locally Advanced Non Small Cell Lung Cancer (NSCLC). International Journal of Radiation, Oncology, Biology, Physics, 66 (3), 476-S477. doi:10.1016/j.ijrobp.2006.07.890 |
Bosquee, L., Rinken, F., Bustin, F., Gustin, M., Broux, R., Angelescu, S., Dekoster, G., & Barthelemy, N. (July 2005). Efficacy and morbidity of a novel induction treatment for locally advanced NSCLC. Lung Cancer, 49 (Suppl. 2), 78. doi:10.1016/S0169-5002(05)80373-3 |
Barthelemy, N. (2005). L’EQUIPE MOBILE DE SOINS PALLIATIFS, LES INFIRMIER(E)S ET LES MEDECINS HOSPITALIERS [Master’s dissertation, UCL- ULB- ULG]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/8871 |
Barthelemy, N., De Jaeger, K., SEPPENWOOLDE, Y., LEBESQUE, J., & KAMINGA, H. (November 2004). Determination of TGF-β1 plasma levels. Authors' reply. International Journal of Radiation, Oncology, Biology, Physics, 60 (4), 1339. |
Deneufbourg, J.-M., BARTHELEMY, N., & NICKERS, P. (2004). CHU de Liège Service de Radiothérapie - Oncologie. Liège, Belgium: Université de Liège CHU de Liège. |
Barthelemy-Brichant, N., Bosquee, L., Cataldo, D., Corhay, J.-L., Gustin, M., Seidel, L., Thiry, A., Ghaye, B., Nizet, M., Albert, A., Deneufbourg, J.-M., Bartsch, P., & Nusgens, B. (01 March 2004). Increased IL-6 and TGF-beta(1) concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy. International Journal of Radiation, Oncology, Biology, Physics, 58 (3), 758-767. doi:10.1016/S0360-3016(03)01614-6 |
Barthelemy, N., Bosquee, L., Bartsch, P., Deneufbourg, J.-M., Albert, A., & Nusgens, B. (August 2003). Interleukin-6 and transforming growth factor-beta1 are increased in bronchoalveolar lavage fluid following thoracic radiotherapy. Lung Cancer, 41 (supp2), 173. |
Barthelemy, N., Bosquee, L., & Quaedvlieg, V. (August 2003). Phase II trial exploring gemcitabine and cisplatin as treatment of patients with non-small cell lung cancer (NSCLC) and inoperable brain metastases. Lung Cancer, 41 (supp2), 145. |
BARTHELEMY, N., Bosquée, L., BARTSCH, P., Albert, A., Deneufbourg, J.-M., & Nusgens, B. (September 2002). Thoracic Radiotherapy for Lung Cancer Increases Local Concentrations of Transforming Growth Factor beta1 (TGFbeta1) [Poster presentation]. 32nd Annual Meeting of the European Society for Radiation Biology ESRB, Liège, Belgium. |
Barthelemy, N., David, J.-L., Bosquee, L., Bury, T., Seidel, L., Albert, A., Bartsch, P., BAUGNET-MAHIEU, L., & Deneufbourg, J.-M. (March 2002). Increased TGFβ1 plasma level in patients with lung cancer: potential mechanisms. European Journal of Clinical Investigation, 32 (3), 193-198. doi:10.1046/j.1365-2362.2002.00956.x |
Barthelemy, N., Sabatier, J., Dewé, W., Albert, A., & Deneufbourg, J.-M. (November 1999). Evaluation of frequency and type of errors detected by a computerized record and verify system during radiation treatment. Radiotherapy and Oncology, 53 (2), 149-54. doi:10.1016/S0167-8140(99)00141-3 |
Bury, T., Corhay, J.-L., Duysinx, B., Daenen, F., Ghaye, B., Barthelemy, N., Rigo, P., & Bartsch, P. (1999). Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer. European Respiratory Journal, 14 (6), 1376-1380. doi:10.1183/09031936.99.14613769 |
Bury, T., BARRETO, A., Daenen, F., BARTHELEMY, N., Ghaye, B., & Rigo, P. (September 1998). Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. European Journal of Nuclear Medicine, 9. doi:10.1007/s002590050291 |
Barthelemy, N., Bosquee, L., Baugnet, Bartsch, P., & Deneufbourg, J.-M. (1997). Pulmonary function changes in patients with lung cancer treated by combined radiation and chemotherapy. Lung Cancer. |
BARTHELEMY, N., BAUGNET, L., BOSQUEE, L., BARTSCH, P., & Deneufbourg, J.-M. (1997). Alteration of pulmonary function related to combined radiation and chemotherapy for lung neoplasm. In J.-C. Pector & J. BONIVER, Book of Abstracts 15th ABEC Meeting (pp. 3). Bruxelles, Belgium: Association belge pour l'étude du Cancer ABEC. |
Barthelemy, N., Johnson, Arriagada, Bonner, Bonomi, Minatel, Enami, Park, Quoix, & Van Houtte. (1997). Post-operative adjuvant therapy for non-small-cell lung cancer. Lung Cancer, 17 (supp 1). doi:10.1016/S0169-5002(97)00040-8 |
Goldstraw, P. G., Rocmans, P. A., Ball, D. L., BARTHELEMY, N., Bonner, J. A., Carette, M.-F., Choi, N. C. H., Emami, B. N., Grunenwald, D. H., Hazuka, M. B., Ihde, D. C., Jassem, J., Kho, G. S., Le Chevalieir, T., Monteau, M., Storme, G. A., & Wagenaarq, S. (1994). Pretreatment minimal staging for non-small cell lung cancer: an updated consensus report. Lung Cancer, 11 (supp 3), 1-S4. doi:10.1016/0169-5002(94)91856-2 |